3623 results for «2598»
3623 results
TAVI Valve-in-valve: Aortic
22 Nov 2020 – From PCR Valves e-Course 2020
Discover various TAVI Valve-in-valve cases: transcatheter treatment of a degenerated sutureless valve using self-expandable prosthesis, emergency TAVI in TAVI for treatment of unexpected prosthetic valve dysfunction, and more!
TAVI in no aortic position
22 Nov 2020 – From PCR Valves e-Course 2020
Discover a selection of TAVI cases: Transcatheter mitral ViV implantation in a history of prior quadruple bioprosthetic valve replacement for rheumatic valvular heart disease, transcatheter tricuspid ViV replacement using next-generation balloon-expandable THV system, and more!
TAVI in mitral
22 Nov 2020 – From PCR Valves e-Course 2020
Learn more about TAVI in mitral and valve-in-mitral annular calcification (ViMAC) with this case.
TAVI in challenging scenarios: patients with previous surgery on aortic root
22 Nov 2020 – From PCR Valves e-Course 2020
Discover a selection of challenging TAVI cases: TAVI in failed Bio-Bentall with severe AR and no accompanying stenosis in a high-risk patient, TAVI after valve sparing aortic root replacement, and more!
Pulmonary valve interventions
22 Nov 2020 – From PCR Valves e-Course 2020
Discover a challenging case about transcatheter pulmonary valve implantation for symptomatic severe pulmonary regurgitation in an adult patient post-intracardiac repair for double outlet RV.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
TAVI as cutting edge
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn all about LOTUS Edge's current status, long term outcome in japan, and clinical use thanks to a selection of challenging cases.
Antithrombotic therapy for AF in bioprosthetic valve
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the anticoagulant therapy for bioprosthetic valves with AF, the optimal stroke prevention strategy after TAVI and the clinical impact of the current data on leaflet thrombosis.
Beyond the evolution! Latest image guided therapy for structural heart disease intervention 2.0 era
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session in japanese to learn more about EchoNavigator, an innovative tool for guidance of interventional procedures in structural heart disease, and discover how it may help you achieve a better patient outcome.
Imaging Day - Case-based imaging for the mitral valve
14 Feb 2020 – From PCR Tokyo Valves 2020
Which imaging is most relevant to clinical decision-making and procedural planning? Find out more on the pathophysiology of mitral regurgitation.
Sizes, wires, and other innovations in TAVI technique and technology
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on innovations in TAVI technique and technology to learn more about new self-expanding TAVR valve sizes and TAVR wires, emerging developments in self-expandable TAVR implant best practices, and discover how to utilize these new technologies and techniques to achieve the best possible outcomes for AS patients.
MitraClip case in point in Japanese
16 Feb 2020 – From PCR Tokyo Valves 2020
Find out more on the MitraClip NT System Japan post market surveillance, the MitraClip best practice and challenging functional MR cases...
Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!
Valve selection for patients with longer life
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about patients with failed surgical bioprosthesis valves' treatment, valve selection impacts clinical and procedural outcomes, and discover some future trends in treating TAVI patients with longer life expectancy which may revolutionize your practice.
Learnings from a decade-long experience of transcatheter mitral valve repair procedures with MitraClipTM
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the patient selection and procedure for MitraClip, and discover how to decide endpoint and assess procedural outcome after this intervention, and how to avoid potential complications, such as chordal entanglement.
Challenging cases on mitral interventions, TAVI and LAA closure
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!
Session for the Co-medicals in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session dedicated to the co-medicals, to discover the nurse's perspective on percutaneous LAA closure, a study on the reduction of scattered radiation exposure in TAVI, and more!
Approach to calcified coronary lesions in a complex patient
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to recognise the need for plaque modification in calcified coronary lesions to enable optimal stent deployment, to discuss the different plaque modification strategies available and to see the step-wise approach to calcified lesions with a simplified algorithm.
This session was originally...
CAD management in TAVI patients
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on optimal management of CAD in TAVI candidates, to discuss tips and tricks to improve future coronary access during TAVI procedure and to review how to optimise management of CAD in post-TAVI patients.
This session was originally presented during...
The year in review in Interventional Cardiology: clinical trials and relevant literature published in 2020
12 Dec 2020 – From GulfPCR-GIM 2020
Watch this session if you want to reflect on key learnings for clinical practice from selected trials published in 2020, to get a rapid overview of the most relevant literature of the year in the fields of coronary, valvular and peripheral interventions and to see examples...
